Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Vostok New Ventures Ltd in connection with its in kind acquisition of BlaBlaCar
Mandate

Vinge advises Vostok New Ventures Ltd in connection with its in kind acquisition of BlaBlaCar

November 30, 2016 Automotive, Mobility and Electrification

The acquisition was made by an issue in kind where the purchase price for the shares in BlaBlaCar consisted of 4,154,495 newly issued shares in Vostok. A prospectus for listing of the Swedish depository receipts representing the issued shares was approved by the Swedish Financial Supervisory Authority and made public on 23 November, 2016. The Swedish depository receipts were admitted to trading on Nasdaq Stockholm on 25 November 2016.

Vostok is an investment company with a special focus on online marketplaces and businesses with strong network effects. As of 30 September 2016, the net asset value of the group was USD 632.44 million. The Swedish depository receipts of Vostok are listed on Nasdaq Stockholm, Mid Cap segment.

Vinge’s team primarily consisted of Jesper Schönbeck, David Andersson, Frida Bäckegren, Joel Wahlberg and Sara Osman.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026